Onychomycosis Drugs Market - Global Outlook and Forecast 2023-2028

Report ID: 1370034 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Onychomycosis Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Onychomycosis Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Onychomycosis Drugs Overall Market Size
    2.1 Global Onychomycosis Drugs Market Size: 2021 VS 2028
    2.2 Global Onychomycosis Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Onychomycosis Drugs Players in Global Market
    3.2 Top Global Onychomycosis Drugs Companies Ranked by Revenue
    3.3 Global Onychomycosis Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Onychomycosis Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Onychomycosis Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Onychomycosis Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Onychomycosis Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Onychomycosis Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Onychomycosis Drugs Market Size Markets, 2021 & 2028
        4.1.2 Oral Drugs
        4.1.3 Topical Drugs
    4.2 By Type - Global Onychomycosis Drugs Revenue & Forecasts
        4.2.1 By Type - Global Onychomycosis Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Onychomycosis Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Onychomycosis Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Onychomycosis Drugs Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Onychomycosis Drugs Revenue & Forecasts
        5.2.1 By Application - Global Onychomycosis Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Onychomycosis Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Onychomycosis Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Onychomycosis Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Onychomycosis Drugs Revenue & Forecasts
        6.2.1 By Region - Global Onychomycosis Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Onychomycosis Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Onychomycosis Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Onychomycosis Drugs Revenue, 2017-2028
        6.3.2 US Onychomycosis Drugs Market Size, 2017-2028
        6.3.3 Canada Onychomycosis Drugs Market Size, 2017-2028
        6.3.4 Mexico Onychomycosis Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Onychomycosis Drugs Revenue, 2017-2028
        6.4.2 Germany Onychomycosis Drugs Market Size, 2017-2028
        6.4.3 France Onychomycosis Drugs Market Size, 2017-2028
        6.4.4 U.K. Onychomycosis Drugs Market Size, 2017-2028
        6.4.5 Italy Onychomycosis Drugs Market Size, 2017-2028
        6.4.6 Russia Onychomycosis Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Onychomycosis Drugs Market Size, 2017-2028
        6.4.8 Benelux Onychomycosis Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Onychomycosis Drugs Revenue, 2017-2028
        6.5.2 China Onychomycosis Drugs Market Size, 2017-2028
        6.5.3 Japan Onychomycosis Drugs Market Size, 2017-2028
        6.5.4 South Korea Onychomycosis Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Onychomycosis Drugs Market Size, 2017-2028
        6.5.6 India Onychomycosis Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Onychomycosis Drugs Revenue, 2017-2028
        6.6.2 Brazil Onychomycosis Drugs Market Size, 2017-2028
        6.6.3 Argentina Onychomycosis Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Onychomycosis Drugs Revenue, 2017-2028
        6.7.2 Turkey Onychomycosis Drugs Market Size, 2017-2028
        6.7.3 Israel Onychomycosis Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Onychomycosis Drugs Market Size, 2017-2028
        6.7.5 UAE Onychomycosis Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Onychomycosis Drugs Major Product Offerings
        7.1.4 Pfizer Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Onychomycosis Drugs Major Product Offerings
        7.2.4 Novartis Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Corporate Summary
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Onychomycosis Drugs Major Product Offerings
        7.3.4 Johnson & Johnson Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.3.5 Johnson & Johnson Key News
    7.4 Bausch Health
        7.4.1 Bausch Health Corporate Summary
        7.4.2 Bausch Health Business Overview
        7.4.3 Bausch Health Onychomycosis Drugs Major Product Offerings
        7.4.4 Bausch Health Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.4.5 Bausch Health Key News
    7.5 Bayer
        7.5.1 Bayer Corporate Summary
        7.5.2 Bayer Business Overview
        7.5.3 Bayer Onychomycosis Drugs Major Product Offerings
        7.5.4 Bayer Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.5.5 Bayer Key News
    7.6 Galderma
        7.6.1 Galderma Corporate Summary
        7.6.2 Galderma Business Overview
        7.6.3 Galderma Onychomycosis Drugs Major Product Offerings
        7.6.4 Galderma Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.6.5 Galderma Key News
    7.7 Moberg Pharma
        7.7.1 Moberg Pharma Corporate Summary
        7.7.2 Moberg Pharma Business Overview
        7.7.3 Moberg Pharma Onychomycosis Drugs Major Product Offerings
        7.7.4 Moberg Pharma Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.7.5 Moberg Pharma Key News
    7.8 Cipla
        7.8.1 Cipla Corporate Summary
        7.8.2 Cipla Business Overview
        7.8.3 Cipla Onychomycosis Drugs Major Product Offerings
        7.8.4 Cipla Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.8.5 Cipla Key News
    7.9 Biofrontera
        7.9.1 Biofrontera Corporate Summary
        7.9.2 Biofrontera Business Overview
        7.9.3 Biofrontera Onychomycosis Drugs Major Product Offerings
        7.9.4 Biofrontera Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.9.5 Biofrontera Key News
    7.10 Leo Pharma
        7.10.1 Leo Pharma Corporate Summary
        7.10.2 Leo Pharma Business Overview
        7.10.3 Leo Pharma Onychomycosis Drugs Major Product Offerings
        7.10.4 Leo Pharma Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.10.5 Leo Pharma Key News
    7.11 Dr. Reddy's Laboratories
        7.11.1 Dr. Reddy's Laboratories Corporate Summary
        7.11.2 Dr. Reddy's Laboratories Business Overview
        7.11.3 Dr. Reddy's Laboratories Onychomycosis Drugs Major Product Offerings
        7.11.4 Dr. Reddy's Laboratories Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.11.5 Dr. Reddy's Laboratories Key News
    7.12 Medimetriks Pharmaceuticals
        7.12.1 Medimetriks Pharmaceuticals Corporate Summary
        7.12.2 Medimetriks Pharmaceuticals Business Overview
        7.12.3 Medimetriks Pharmaceuticals Onychomycosis Drugs Major Product Offerings
        7.12.4 Medimetriks Pharmaceuticals Onychomycosis Drugs Revenue in Global Market (2017-2022)
        7.12.5 Medimetriks Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Onychomycosis Drugs Market Opportunities & Trends in Global Market
    Table 2. Onychomycosis Drugs Market Drivers in Global Market
    Table 3. Onychomycosis Drugs Market Restraints in Global Market
    Table 4. Key Players of Onychomycosis Drugs in Global Market
    Table 5. Top Onychomycosis Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Onychomycosis Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Onychomycosis Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Onychomycosis Drugs Product Type
    Table 9. List of Global Tier 1 Onychomycosis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Onychomycosis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Onychomycosis Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Onychomycosis Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Onychomycosis Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Onychomycosis Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Onychomycosis Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Onychomycosis Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Onychomycosis Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Onychomycosis Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Onychomycosis Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Onychomycosis Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Onychomycosis Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Onychomycosis Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Onychomycosis Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Onychomycosis Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Onychomycosis Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Onychomycosis Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Onychomycosis Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Onychomycosis Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Onychomycosis Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Onychomycosis Drugs Product Offerings
    Table 32. Pfizer Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Onychomycosis Drugs Product Offerings
    Table 35. Novartis Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Johnson & Johnson Corporate Summary
    Table 37. Johnson & Johnson Onychomycosis Drugs Product Offerings
    Table 38. Johnson & Johnson Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Bausch Health Corporate Summary
    Table 40. Bausch Health Onychomycosis Drugs Product Offerings
    Table 41. Bausch Health Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Bayer Corporate Summary
    Table 43. Bayer Onychomycosis Drugs Product Offerings
    Table 44. Bayer Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Galderma Corporate Summary
    Table 46. Galderma Onychomycosis Drugs Product Offerings
    Table 47. Galderma Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Moberg Pharma Corporate Summary
    Table 49. Moberg Pharma Onychomycosis Drugs Product Offerings
    Table 50. Moberg Pharma Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Cipla Corporate Summary
    Table 52. Cipla Onychomycosis Drugs Product Offerings
    Table 53. Cipla Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Biofrontera Corporate Summary
    Table 55. Biofrontera Onychomycosis Drugs Product Offerings
    Table 56. Biofrontera Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Leo Pharma Corporate Summary
    Table 58. Leo Pharma Onychomycosis Drugs Product Offerings
    Table 59. Leo Pharma Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. Dr. Reddy's Laboratories Corporate Summary
    Table 61. Dr. Reddy's Laboratories Onychomycosis Drugs Product Offerings
    Table 62. Dr. Reddy's Laboratories Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
    Table 63. Medimetriks Pharmaceuticals Corporate Summary
    Table 64. Medimetriks Pharmaceuticals Onychomycosis Drugs Product Offerings
    Table 65. Medimetriks Pharmaceuticals Onychomycosis Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Onychomycosis Drugs Segment by Type in 2021
    Figure 2. Onychomycosis Drugs Segment by Application in 2021
    Figure 3. Global Onychomycosis Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Onychomycosis Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Onychomycosis Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Onychomycosis Drugs Revenue in 2021
    Figure 8. By Type - Global Onychomycosis Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Onychomycosis Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Onychomycosis Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Onychomycosis Drugs Revenue Market Share, 2017-2028
    Figure 12. US Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Onychomycosis Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Onychomycosis Drugs Revenue Market Share, 2017-2028
    Figure 24. China Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Onychomycosis Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Onychomycosis Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Onychomycosis Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Johnson & Johnson Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bausch Health Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Bayer Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Galderma Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Moberg Pharma Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Cipla Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Biofrontera Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Leo Pharma Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Dr. Reddy's Laboratories Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Medimetriks Pharmaceuticals Onychomycosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Onychomycosis Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Onychomycosis Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Onychomycosis Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports